News

Press release

Johnson & Johnson Innovation Opens JLABS @ Shanghai in Collaboration with Shanghai Pharma Engine Company Ltd.

By JLABS

Read full story
Press release

Johnson & Johnson Innovation Announces Collaboration with National Academy of Medicine to Help People Live Longer, Healthier Lives

By JLABS

Read full story
JLABS @ Washington DC Launch
Press release
April 09th 2019 -

Johnson & Johnson Innovation and Children’s National Health System* to Launch JLABS @ Washington, DC at the new Children’s National Research and Innovation Campus in 2020

Read story
Other news

Syndesi Therapeutics Awarded Non-dilutive Funding of up to €3.2M for Development of its Lead Program, SDI-118, Aimed at Treating Cognitive Impairment

By JLABS

Read full story
Press release

Johnson & Johnson Innovation Launches Reimagining Respiratory Protection QuickFire Challenge in Collaboration with the U.S. Department of Health and Human Services

By JLABS

Read full story
Press release

JLABS Companies Have Secured $11.6 Billion in Financing, a 23 Percent Gain from 2017, According to 2018 JLABS Impact Report

By JLABS

Read full story
Other news

Why the City That Never Sleeps Is Ready to Reinvent Healthcare With JLABS @ NYC

By Molly Triffin

Read full story
Press release

Johnson & Johnson Innovation Announces Launch of Shanghai Lung Cancer Innovation QuickFire Challenge

By JLABS

Read full story
Other news

Melinda Richter appointed as the new Vice Chair of the California Life Sciences Association

By CLSA Press Release

Read full story
Other news

Knowledge for Growth 2018 Recap

By Janssen Belgium

Read full story
Other news

Life Sciences Real Estate Development Symposium - June 12

By New York Real Estate Journal

Read full story
Other news

New York City was built on big dreams, and JLABS is here to help make yours a reality

By JLABS

Read full story
Other news

Want to know more about the JLABS Portfolio?

By JLABS

Read full story
Other news

Melinda Richter to join esteemed panel of judges for the 2018 Bloom Burton Award

By Bloom Burton & Co. Press Release

Read full story
Other news

IDEAYA Biosciences raised a $94M crossover Series B financing to develop next generation biomarker-enabled synthetic lethality therapies.

By Ideaya Biosciences

Read full story